Skip to content

ENDOCYTE INC: 10-K filed 2013-03-18

What ENDOCYTE INC reported in its annual report filed 2013-03-18 (fiscal FY 2012): 34 published measures, 139 facts as tagged in accession 0001144204-13-015715.

This filing

Form
10-K (annual report)
Filed
2013-03-18
Fiscal period
fiscal FY 2012
Accession
0001144204-13-015715 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ENDOCYTE INC filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2012-12-31214,078,709USD
At 2011-12-31131,675,104USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2012-12-31114,505,431USD
At 2011-12-3118,303,181USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2012-12-3199,573,278USD
At 2011-12-31113,371,923USD
At 2010-12-31-96,911,023USD
At 2009-12-31-76,057,563USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2012-12-3133,996,866USD
At 2011-12-3161,352,483USD
At 2010-12-3116,872,783USD
At 2009-12-318,699,372USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2012-10-01 to 2012-12-31-849USD92
2012-01-01 to 2012-12-31-17,291,758USD366
2012-07-01 to 2012-09-30-1,239USD92
2012-04-01 to 2012-06-30-5,434USD91
2012-01-01 to 2012-03-31-9,770USD91
2011-10-01 to 2011-12-31-10,754USD92
2011-01-01 to 2011-12-31-40,531,613USD365
2011-07-01 to 2011-09-30-12,070USD92
2011-04-01 to 2011-06-30-10,519USD91
2011-01-01 to 2011-03-31-7,189USD90
2010-01-01 to 2010-12-31-20,092,722USD365

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2012-01-01 to 2012-12-3189,191,511USD366
2011-01-01 to 2011-12-31-34,584,616USD365
2010-01-01 to 2010-12-31-20,745,146USD365

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2012-01-01 to 2012-12-311,862,872USD366
2011-01-01 to 2011-12-31234,969USD365
2010-01-01 to 2010-12-31200,527USD365

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2012-10-01 to 2012-12-3114,454USD92
2012-01-01 to 2012-12-3134,682,111USD366
2012-07-01 to 2012-09-3012,415USD92
2012-04-01 to 2012-06-307,813USD91
2012-01-01 to 2012-03-310USD91
2011-10-01 to 2011-12-31191USD92
2011-01-01 to 2011-12-31191,023USD365
2011-07-01 to 2011-09-300USD92
2011-04-01 to 2011-06-300USD91
2011-01-01 to 2011-03-310USD90
2010-01-01 to 2010-12-310USD365

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2012-01-01 to 2012-12-31-13,152,768USD366
2011-01-01 to 2011-12-31146,381,132USD365
2010-01-01 to 2010-12-3113,907,808USD365

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2012-01-01 to 2012-12-31-103,395,067USD366
2011-01-01 to 2011-12-31-67,311,098USD365
2010-01-01 to 2010-12-3115,010,749USD365

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2012-12-31-155,892,278USD
At 2011-12-31-138,600,520USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2012-12-313,166,905USD
At 2011-12-311,107,851USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2012-01-01 to 2012-12-313,022,693USD366
2011-01-01 to 2011-12-311,960,345USD365
2010-01-01 to 2010-12-31523,562USD365

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2012-10-01 to 2012-12-31-1,014USD92
2012-01-01 to 2012-12-31-16,042,676USD366
2012-07-01 to 2012-09-30-1,330USD92
2012-04-01 to 2012-06-30-4,188USD91
2012-01-01 to 2012-03-31-9,511USD91
2011-10-01 to 2011-12-31-10,424USD92
2011-01-01 to 2011-12-31-38,636,723USD365
2011-07-01 to 2011-09-30-11,638USD92
2011-04-01 to 2011-06-30-10,062USD91
2011-01-01 to 2011-03-31-6,513USD90
2010-01-01 to 2010-12-31-20,599,966USD365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2012-12-31184,824,842USD
At 2011-12-31129,756,024USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2012-01-01 to 2012-12-31628,993USD366
2011-01-01 to 2011-12-311,987,873USD365
2010-01-01 to 2010-12-311,064,556USD365

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2012-12-3162,470,225USD
At 2011-12-315,470,002USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2012-12-313,647,967USD
At 2011-12-312,125,500USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2012-01-01 to 2012-12-3150,724,787USD366
2011-01-01 to 2011-12-3138,827,746USD365
2010-01-01 to 2010-12-3120,599,966USD365

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2012-10-01 to 2012-12-3110,518USD92
2012-01-01 to 2012-12-3135,670,418USD366
2012-07-01 to 2012-09-309,930USD92
2012-04-01 to 2012-06-308,806USD91
2012-01-01 to 2012-03-316,417USD91
2011-10-01 to 2011-12-317,753USD92
2011-01-01 to 2011-12-3128,827,746USD365
2011-07-01 to 2011-09-308,915USD92
2011-04-01 to 2011-06-307,721USD91
2011-01-01 to 2011-03-314,439USD90
2010-01-01 to 2010-12-3114,560,821USD365
2007-10-01 to 2007-10-31300,000USD31

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2012-12-3135,919,019shares
At 2011-12-3135,784,485shares

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2012-12-3172,749USD
At 2011-12-31-6,264USD
At 2010-12-310USD
At 2009-12-31-2,177USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

PeriodValueUnitDays
At 2012-12-310USD
At 2011-12-3112,833,179USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2012-12-315,300,759USD
At 2011-12-313,157,698USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2012-12-312,133,854USD
At 2011-12-312,049,847USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2012-12-31546,313USD
At 2011-12-31811,229USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2012-12-311,902,910USD
At 2011-12-311,540,749USD

Net deferred tax assets

Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.

PeriodValueUnitDays
At 2012-12-310USD
At 2011-12-310USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2012-01-01 to 2012-12-31-17,212,745USD366
2011-01-01 to 2011-12-31-40,537,877USD365
2010-01-01 to 2010-12-31-20,094,899USD365

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2012-10-01 to 2012-12-314,950USD92
2012-01-01 to 2012-12-3115,054,369USD366
2012-07-01 to 2012-09-303,815USD92
2012-04-01 to 2012-06-303,195USD91
2012-01-01 to 2012-03-313,094USD91
2011-10-01 to 2011-12-312,862USD92
2011-01-01 to 2011-12-3110,000,000USD365
2011-07-01 to 2011-09-302,723USD92
2011-04-01 to 2011-06-302,341USD91
2011-01-01 to 2011-03-312,074USD90
2010-01-01 to 2010-12-316,039,145USD365

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2012-01-01 to 2012-12-31358,367USD366
2011-01-01 to 2011-12-31262,518USD365
2010-01-01 to 2010-12-31260,571USD365

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2012-10-01 to 2012-12-31-25USD92
2012-01-01 to 2012-12-31-947,834USD366
2012-07-01 to 2012-09-30-4USD92
2012-04-01 to 2012-06-30-994USD91
2012-01-01 to 2012-03-3175USD91
2011-10-01 to 2011-12-31-17USD92
2011-01-01 to 2011-12-31-36,466USD365
2011-07-01 to 2011-09-30-18USD92
2011-04-01 to 2011-06-30-4USD91
2011-01-01 to 2011-03-313USD90
2010-01-01 to 2010-12-311,564,117USD365

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2011-08-01 to 2011-08-0266,700,000USD2
2011-02-01 to 2011-02-0978,200,000USD9

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2012-01-01 to 2012-12-31524,936USD366
2011-01-01 to 2011-12-31943,024USD365
2010-01-01 to 2010-12-31-118,140USD365

Inspect the source

Entity
ENDOCYTE INC / CIK 0001235007
Captured
SEC response SHA-256
fa7da76c073b3895ba6769212bf598e872bbf5f159d8c19a8ae123614d925339

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001235007.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))